Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures

Author： Rektor Ivan  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.2, 2013-02, pp. : 225-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eslicarbazepine acetate: a guide to its use as adjunctive therapy in partial-onset seizures

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 10, 2011-10 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Lacosamide: new adjunctive treatment option for partial-onset seizures

By Chung Steve S  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1595-1602

Informa Healthcare

Access to resources Recommend Favorite

The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics

By Borowicz K.K.   Gasior M.   Kleinrok Z.   Czuczwar S.J.  

European Journal of Pharmacology, Vol. 281, Iss. 3, 1995-08 ,pp. : 319-326

Elsevier

Access to resources Recommend Favorite

Comparison of neuroprotective efficacy of competitive and non-competitive AMPA antagonist in vitro

By Kovacs A.D.   Szabo G.  

Environmental Toxicology and Pharmacology, Vol. 3, Iss. 1, 1997-02 ,pp. : 69-72

Elsevier

Access to resources Recommend Favorite

Lacosamide: In Partial-Onset Seizures

By Cross Sarah A.   Curran Monique P.  

Drugs, Vol. 69, Iss. 4, 2009-01 ,pp. : 449-459

Adis International

Access to resources Recommend Favorite